258 related articles for article (PubMed ID: 32003061)
1. Second cycle of intralesional Collagenase Clostridium histolyticum for Peyronie's disease using the modified shortened protocol: Results from a retrospective analysis.
Capece M; Arcaniolo D; Manfredi C; Palmieri A; De Sio M; Verze P; Fusco F; Longo N; Mirone V
Andrologia; 2020 Apr; 52(3):e13527. PubMed ID: 32003061
[TBL] [Abstract][Full Text] [Related]
2. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
[TBL] [Abstract][Full Text] [Related]
3. Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocol.
Abdel Raheem A; Capece M; Kalejaiye O; Abdel-Raheem T; Falcone M; Johnson M; Ralph OG; Garaffa G; Christopher AN; Ralph DJ
BJU Int; 2017 Nov; 120(5):717-723. PubMed ID: 28612401
[TBL] [Abstract][Full Text] [Related]
4. Intralesional Collagenase Clostridium histolyticum Causes Meaningful Improvement in Men with Peyronie's Disease: Results of a Multi-Institutional Analysis.
Hellstrom WJG; Tue Nguyen HM; Alzweri L; Chung A; Virasoro R; Tapscott A; Ziegelmann M; Trost L; Gelbard M
J Urol; 2019 Apr; 201(4):777-782. PubMed ID: 30672843
[TBL] [Abstract][Full Text] [Related]
5. Predictive Factors of Patients' and Their Partners' Sexual Function Improvement After Collagenase Clostridium Histolyticum Injection for Peyronie's Disease: Results From a Multi-Center Single-Arm Study.
Cocci A; Russo GI; Salonia A; Cito G; Regis F; Polloni G; Giubilei G; Cacciamani G; Capece M; Falcone M; Greco I; Timpano M; Minervini A; Gacci M; Cai T; Garaffa G; Giammusso B; Arcaniolo D; Mirone V; Mondaini N
J Sex Med; 2018 May; 15(5):716-721. PubMed ID: 29699756
[TBL] [Abstract][Full Text] [Related]
6. Predictors of Curvature Improvement in Men With Peyronie's Disease Treated With Intralesional Collagenase Clostridium Histolyticum.
Flores JM; Nascimento B; Punjani N; Salter CA; Bernie HL; Taniguchi H; Miranda E; Terrier JE; Schofield E; Jenkins L; Mulhall JP
J Sex Med; 2022 Nov; 19(11):1680-1686. PubMed ID: 36127227
[TBL] [Abstract][Full Text] [Related]
7. Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie's Disease.
Ziegelmann MJ; Viers BR; McAlvany KL; Bailey GC; Savage JB; Trost LW
J Urol; 2016 Apr; 195(4 Pt 1):1051-6. PubMed ID: 26476353
[TBL] [Abstract][Full Text] [Related]
8. Peyronie's disease response to intralesional collagenase clostridium histolyticum therapy is independent of baseline testosterone.
Schneider D; O'Leary M; Amini E; Miller J; Hassas N; Nguyen J; Hammad MAM; Barham D; Yafi FA
Andrology; 2024 May; 12(4):830-834. PubMed ID: 37753943
[TBL] [Abstract][Full Text] [Related]
9. Long-term Curvature Deformity Characterization in Men Previously Treated With Collagenase Clostridium Histolyticum for Peyronie's Disease, Subgrouped by Penile Plaque Calcification.
Goldstein I; McLane MP; Xiang Q; Wolfe HR; Hu Y; Gelbard MK
Urology; 2020 Dec; 146():145-151. PubMed ID: 32896582
[TBL] [Abstract][Full Text] [Related]
10. Sildenafil 25 mg ODT + Collagenase Clostridium hystoliticum vs Collagenase Clostridium hystoliticum Alone for the Management of Peyronie's Disease: A Matched-Pair Comparison Analysis.
Cocci A; Cito G; Urzì D; Minervini A; Di Maida F; Sessa F; Mari A; Campi R; Falcone M; Capece M; Morelli G; Cacciamani G; Rizzo M; Polito C; Giammusso B; Morgia G; Verze P; Salonia A; Cai T; Mirone V; Mondaini N; Russo GI
J Sex Med; 2018 Oct; 15(10):1472-1477. PubMed ID: 30245025
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Collagenase Clostridium histolyticum in the Treatment of Acute-Phase Peyronie's Disease.
Nguyen HMT; Anaissie J; DeLay KJ; Yafi FA; Sikka SC; Hellstrom WJG
J Sex Med; 2017 Oct; 14(10):1220-1225. PubMed ID: 28874331
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Peyronie's Disease With Collagenase Clostridium histolyticum and Vacuum Therapy: A Randomized, Open-Label Pilot Study.
Ralph DJ; Abdel Raheem A; Liu G
J Sex Med; 2017 Nov; 14(11):1430-1437. PubMed ID: 28974406
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Surgery in Peyronie's Disease Following Intralesional Collagenase Clostridium Histolyticum Injections.
Bazzi M; Jamil ML; Dabaja AA
Curr Urol Rep; 2019 Jun; 20(8):42. PubMed ID: 31201571
[TBL] [Abstract][Full Text] [Related]
14. Optimizing collagenase Clostridium histolyticum therapy for Peyronie's disease using a novel approach with percutaneous needle tunnelling.
Fernández-Pascual E; González-García FJ; Angulo J; Cerezo E; Quintana LM; Turo J; Martínez-Ballesteros C; Carballido J; Martínez-Salamanca JI
BJU Int; 2019 Dec; 124(6):1055-1062. PubMed ID: 31033130
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of collagenase Clostridium histolyticum in Peyronie's disease following a modified treatment protocol.
García Cruz E; Mercader Barrull C; Camacho Rovira D; Alcaraz Asensio A
Actas Urol Esp (Engl Ed); 2021 Apr; 45(3):215-219. PubMed ID: 33531284
[TBL] [Abstract][Full Text] [Related]
16. Results of SMSNA Survey Regarding Complications Following Intralesional Injection Therapy With Collagenase Clostridium Histolyticum for Peyronie's Disease.
Yafi FA; Anaissie J; Zurawin J; Sikka SC; Hellstrom WJ
J Sex Med; 2016 Apr; 13(4):684-9. PubMed ID: 27045265
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Safety and Curvature Deformity Characterization in Patients Previously Treated with Collagenase clostridium Histolyticum for Peyronie's Disease.
Goldstein I; Lipshultz LI; McLane M; Hu Y; Xiang Q; Liu G; Vijayan S; Gelbard MK
J Urol; 2020 Jun; 203(6):1191-1197. PubMed ID: 31922462
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies.
Gelbard M; Goldstein I; Hellstrom WJ; McMahon CG; Smith T; Tursi J; Jones N; Kaufman GJ; Carson CC
J Urol; 2013 Jul; 190(1):199-207. PubMed ID: 23376148
[TBL] [Abstract][Full Text] [Related]
19. Collagenase Clostridium histolyticum Treatment Improves Degree of Curvature in Peyronie's Disease with Calcified Plaques.
Masterson TA; Atuluru P; Zucker I; Molina M; Ibrahim E; Nackeeran S; Kava B; Ramasamy R
Eur Urol Focus; 2023 Jan; 9(1):55-59. PubMed ID: 36272924
[TBL] [Abstract][Full Text] [Related]
20. Surgical correction of persistent Peyronie's disease following collagenase clostridium histolyticum treatment.
Levine LA; Larsen SM
J Sex Med; 2015 Jan; 12(1):259-64. PubMed ID: 25345351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
